APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pulmonary Surfactant

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pulmonary Surfactant Industry Research Report 2026

23 December 2025136 pages

Choose your research edition.

Industry ResearchPulmonary Surfactant Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmonary Surfactant Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Pulmonary Surfactant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmonary Surfactant Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmonary Surfactant Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pulmonary Surfactant market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Pulmonary Surfactant is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Pulmonary Surfactant is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Pulmonary Surfactant is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Pulmonary Surfactant include Abbott, Nanjing Norris Pharm Technology, AbbVie, XpressBio, Windtree Therapeutics, Tekzima (Noargen), Reddot Biotech, ONY Biotech and Lyomark Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Pulmonary Surfactant market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pulmonary Surfactant Market by Company

Abbott

Nanjing Norris Pharm Technology

AbbVie

XpressBio

Windtree Therapeutics

Tekzima (Noargen)

Reddot Biotech

ONY Biotech

Lyomark Pharma

LSBio

Creative Diagnostics

Boehringer Ingelheim

Biorbyt

Biomatik

Aviva Systems Biology

Pulmonary Surfactant Segment by Type

Synthetic Pulmonary Surfactants

Animal Derived Surfactants

Pulmonary Surfactant Segment by Application

Hospital

laboratory

Others

Pulmonary Surfactant Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Surfactant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Surfactant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Surfactant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pulmonary Surfactant manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pulmonary Surfactant by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pulmonary Surfactant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pulmonary Surfactant Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pulmonary Surfactant Sales (k units) of Manufacturers (2021-2026) Table 7. Global Pulmonary Surfactant Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pulmonary Surfactant Revenue of Manufacturers (2021-2026) Table 9. Global Pulmonary Surfactant Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pulmonary Surfactant Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Pulmonary Surfactant Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pulmonary Surfactant, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pulmonary Surfactant, Product Type & Application Table 14. Global Pulmonary Surfactant Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pulmonary Surfactant by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Abbott Company Information Table 19. Abbott Business Overview Table 20. Abbott Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Abbott Pulmonary Surfactant Product Portfolio Table 22. Abbott Recent Developments Table 23. Nanjing Norris Pharm Technology Company Information Table 24. Nanjing Norris Pharm Technology Business Overview Table 25. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolio Table 27. Nanjing Norris Pharm Technology Recent Developments Table 28. AbbVie Company Information Table 29. AbbVie Business Overview Table 30. AbbVie Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. AbbVie Pulmonary Surfactant Product Portfolio Table 32. AbbVie Recent Developments Table 33. XpressBio Company Information Table 34. XpressBio Business Overview Table 35. XpressBio Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. XpressBio Pulmonary Surfactant Product Portfolio Table 37. XpressBio Recent Developments Table 38. Windtree Therapeutics Company Information Table 39. Windtree Therapeutics Business Overview Table 40. Windtree Therapeutics Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Windtree Therapeutics Pulmonary Surfactant Product Portfolio Table 42. Windtree Therapeutics Recent Developments Table 43. Tekzima (Noargen) Company Information Table 44. Tekzima (Noargen) Business Overview Table 45. Tekzima (Noargen) Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Tekzima (Noargen) Pulmonary Surfactant Product Portfolio Table 47. Tekzima (Noargen) Recent Developments Table 48. Reddot Biotech Company Information Table 49. Reddot Biotech Business Overview Table 50. Reddot Biotech Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Reddot Biotech Pulmonary Surfactant Product Portfolio Table 52. Reddot Biotech Recent Developments Table 53. ONY Biotech Company Information Table 54. ONY Biotech Business Overview Table 55. ONY Biotech Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. ONY Biotech Pulmonary Surfactant Product Portfolio Table 57. ONY Biotech Recent Developments Table 58. Lyomark Pharma Company Information Table 59. Lyomark Pharma Business Overview Table 60. Lyomark Pharma Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Lyomark Pharma Pulmonary Surfactant Product Portfolio Table 62. Lyomark Pharma Recent Developments Table 63. LSBio Company Information Table 64. LSBio Business Overview Table 65. LSBio Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. LSBio Pulmonary Surfactant Product Portfolio Table 67. LSBio Recent Developments Table 68. Creative Diagnostics Company Information Table 69. Creative Diagnostics Business Overview Table 70. Creative Diagnostics Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Creative Diagnostics Pulmonary Surfactant Product Portfolio Table 72. Creative Diagnostics Recent Developments Table 73. Boehringer Ingelheim Company Information Table 74. Boehringer Ingelheim Business Overview Table 75. Boehringer Ingelheim Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Boehringer Ingelheim Pulmonary Surfactant Product Portfolio Table 77. Boehringer Ingelheim Recent Developments Table 78. Biorbyt Company Information Table 79. Biorbyt Business Overview Table 80. Biorbyt Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Biorbyt Pulmonary Surfactant Product Portfolio Table 82. Biorbyt Recent Developments Table 83. Biomatik Company Information Table 84. Biomatik Business Overview Table 85. Biomatik Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Biomatik Pulmonary Surfactant Product Portfolio Table 87. Biomatik Recent Developments Table 88. Aviva Systems Biology Company Information Table 89. Aviva Systems Biology Business Overview Table 90. Aviva Systems Biology Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Aviva Systems Biology Pulmonary Surfactant Product Portfolio Table 92. Aviva Systems Biology Recent Developments Table 93. Global Pulmonary Surfactant Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Pulmonary Surfactant Sales by Region (2021-2026) & (k units) Table 95. Global Pulmonary Surfactant Sales Market Share by Region (2021-2026) Table 96. Global Pulmonary Surfactant Sales by Region (2027-2032) & (k units) Table 97. Global Pulmonary Surfactant Sales Market Share by Region (2027-2032) Table 98. Global Pulmonary Surfactant Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Pulmonary Surfactant Revenue Market Share by Region (2021-2026) Table 100. Global Pulmonary Surfactant Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Pulmonary Surfactant Revenue Market Share by Region (2027-2032) Table 102. North America Pulmonary Surfactant Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 104. North America Pulmonary Surfactant Sales by Country (2027-2032) & (k units) Table 105. North America Pulmonary Surfactant Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Pulmonary Surfactant Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Pulmonary Surfactant Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 109. Europe Pulmonary Surfactant Sales by Country (2027-2032) & (k units) Table 110. Europe Pulmonary Surfactant Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Pulmonary Surfactant Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Pulmonary Surfactant Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 114. Asia Pacific Pulmonary Surfactant Sales by Country (2027-2032) & (k units) Table 115. Asia Pacific Pulmonary Surfactant Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Pulmonary Surfactant Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Pulmonary Surfactant Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 119. South America Pulmonary Surfactant Sales by Country (2027-2032) & (k units) Table 120. South America Pulmonary Surfactant Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Pulmonary Surfactant Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Pulmonary Surfactant Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 124. Middle East and Africa Pulmonary Surfactant Sales by Country (2027-2032) & (k units) Table 125. Middle East and Africa Pulmonary Surfactant Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Pulmonary Surfactant Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Pulmonary Surfactant Sales by Type (2021-2026) & (k units) Table 128. Global Pulmonary Surfactant Sales by Type (2027-2032) & (k units) Table 129. Global Pulmonary Surfactant Sales Market Share by Type (2021-2026) Table 130. Global Pulmonary Surfactant Sales Market Share by Type (2027-2032) Table 131. Global Pulmonary Surfactant Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Pulmonary Surfactant Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Pulmonary Surfactant Revenue Market Share by Type (2021-2026) Table 134. Global Pulmonary Surfactant Revenue Market Share by Type (2027-2032) Table 135. Global Pulmonary Surfactant Price by Type (2021-2026) & (US$/unit) Table 136. Global Pulmonary Surfactant Price by Type (2027-2032) & (US$/unit) Table 137. Global Pulmonary Surfactant Sales by Application (2021-2026) & (k units) Table 138. Global Pulmonary Surfactant Sales by Application (2027-2032) & (k units) Table 139. Global Pulmonary Surfactant Sales Market Share by Application (2021-2026) Table 140. Global Pulmonary Surfactant Sales Market Share by Application (2027-2032) Table 141. Global Pulmonary Surfactant Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Pulmonary Surfactant Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Pulmonary Surfactant Revenue Market Share by Application (2021-2026) Table 144. Global Pulmonary Surfactant Revenue Market Share by Application (2027-2032) Table 145. Global Pulmonary Surfactant Price by Application (2021-2026) & (US$/unit) Table 146. Global Pulmonary Surfactant Price by Application (2027-2032) & (US$/unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Pulmonary Surfactant Distributors List Table 150. Pulmonary Surfactant Customers List Table 151. Pulmonary Surfactant Industry Trends Table 152. Pulmonary Surfactant Industry Drivers Table 153. Pulmonary Surfactant Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pulmonary Surfactant Product Image Figure 5. Global Pulmonary Surfactant Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pulmonary Surfactant Market Size (2021-2032) & (US$ Million) Figure 7. Global Pulmonary Surfactant Sales (2021-2032) & (k units) Figure 8. Global Pulmonary Surfactant Average Price (US$/unit) & (2021-2032) Figure 9. Synthetic Pulmonary Surfactants Product Image Figure 10. Animal Derived Surfactants Product Image Figure 11. Hospital Product Image Figure 12. laboratory Product Image Figure 13. Others Product Image Figure 14. Global Pulmonary Surfactant Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Pulmonary Surfactant, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Pulmonary Surfactant Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Pulmonary Surfactant Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Pulmonary Surfactant Sales by Region in 2025 Figure 20. Global Pulmonary Surfactant Revenue by Region in 2025 Figure 21. North America Pulmonary Surfactant Market Size by Country in 2025 Figure 22. North America Pulmonary Surfactant Sales Market Share by Country (2021-2032) Figure 23. North America Pulmonary Surfactant Revenue Market Share by Country (2021-2032) Figure 24. United States Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Pulmonary Surfactant Market Size by Country in 2025 Figure 28. Europe Pulmonary Surfactant Sales Market Share by Country (2021-2032) Figure 29. Europe Pulmonary Surfactant Revenue Market Share by Country (2021-2032) Figure 30. Germany Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Pulmonary Surfactant Market Size by Country in 2025 Figure 41. Asia Pacific Pulmonary Surfactant Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Pulmonary Surfactant Revenue Market Share by Country (2021-2032) Figure 43. China Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Pulmonary Surfactant Market Size by Country in 2025 Figure 52. South America Pulmonary Surfactant Sales Market Share by Country (2021-2032) Figure 53. South America Pulmonary Surfactant Revenue Market Share by Country (2021-2032) Figure 54. Brazil Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Pulmonary Surfactant Market Size by Country in 2025 Figure 58. Middle East and Africa Pulmonary Surfactant Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Pulmonary Surfactant Revenue Market Share by Country (2021-2032) Figure 60. Egypt Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Pulmonary Surfactant Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Pulmonary Surfactant Sales Market Share by Type (2021-2032) Figure 66. Global Pulmonary Surfactant Revenue Market Share by Type (2021-2032) Figure 67. Global Pulmonary Surfactant Price (US$/unit) by Type (2021-2032) Figure 68. Global Pulmonary Surfactant Sales Market Share by Application (2021-2032) Figure 69. Global Pulmonary Surfactant Revenue Market Share by Application (2021-2032) Figure 70. Global Pulmonary Surfactant Price (US$/unit) by Application (2021-2032) Figure 71. Pulmonary Surfactant Value Chain Figure 72. Pulmonary Surfactant Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Pulmonary Surfactant Industry Opportunities and Challenges

Scope & coverage.

Types
  • Synthetic Pulmonary Surfactants
  • Animal Derived Surfactants
Applications
  • Hospital
  • laboratory
  • Others
Companies covered
  • Abbott
  • Nanjing Norris Pharm Technology
  • AbbVie
  • XpressBio
  • Windtree Therapeutics
  • Tekzima (Noargen)
  • Reddot Biotech
  • ONY Biotech
  • Lyomark Pharma
  • LSBio
  • Creative Diagnostics
  • Boehringer Ingelheim
  • Biorbyt
  • Biomatik
  • Aviva Systems Biology

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pulmonary Surfactant Market Size (2021-2032)
  4. 2.2.2 Global Pulmonary Surfactant Sales (2021-2032)
  5. 2.2.3 Global Pulmonary Surfactant Market Average Price (2021-2032)
  6. 2.3 Pulmonary Surfactant by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Synthetic Pulmonary Surfactants
  9. 2.3.3 Animal Derived Surfactants
  10. 2.4 Pulmonary Surfactant by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 laboratory
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pulmonary Surfactant Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pulmonary Surfactant Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Pulmonary Surfactant Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pulmonary Surfactant Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pulmonary Surfactant Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pulmonary Surfactant, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pulmonary Surfactant, Product Type & Application
  8. 3.8 Global Manufacturers of Pulmonary Surfactant, Established Date
  9. 3.9 Global Pulmonary Surfactant Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Abbott
  2. 4.1.1 Abbott Company Information
  3. 4.1.2 Abbott Business Overview
  4. 4.1.3 Abbott Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Abbott Pulmonary Surfactant Product Portfolio
  6. 4.1.5 Abbott Recent Developments
  7. 4.2 Nanjing Norris Pharm Technology
  8. 4.2.1 Nanjing Norris Pharm Technology Company Information
  9. 4.2.2 Nanjing Norris Pharm Technology Business Overview
  10. 4.2.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolio
  12. 4.2.5 Nanjing Norris Pharm Technology Recent Developments
  13. 4.3 AbbVie
  14. 4.3.1 AbbVie Company Information
  15. 4.3.2 AbbVie Business Overview
  16. 4.3.3 AbbVie Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 AbbVie Pulmonary Surfactant Product Portfolio
  18. 4.3.5 AbbVie Recent Developments
  19. 4.4 XpressBio
  20. 4.4.1 XpressBio Company Information
  21. 4.4.2 XpressBio Business Overview
  22. 4.4.3 XpressBio Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 XpressBio Pulmonary Surfactant Product Portfolio
  24. 4.4.5 XpressBio Recent Developments
  25. 4.5 Windtree Therapeutics
  26. 4.5.1 Windtree Therapeutics Company Information
  27. 4.5.2 Windtree Therapeutics Business Overview
  28. 4.5.3 Windtree Therapeutics Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Windtree Therapeutics Pulmonary Surfactant Product Portfolio
  30. 4.5.5 Windtree Therapeutics Recent Developments
  31. 4.6 Tekzima (Noargen)
  32. 4.6.1 Tekzima (Noargen) Company Information
  33. 4.6.2 Tekzima (Noargen) Business Overview
  34. 4.6.3 Tekzima (Noargen) Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Tekzima (Noargen) Pulmonary Surfactant Product Portfolio
  36. 4.6.5 Tekzima (Noargen) Recent Developments
  37. 4.7 Reddot Biotech
  38. 4.7.1 Reddot Biotech Company Information
  39. 4.7.2 Reddot Biotech Business Overview
  40. 4.7.3 Reddot Biotech Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Reddot Biotech Pulmonary Surfactant Product Portfolio
  42. 4.7.5 Reddot Biotech Recent Developments
  43. 4.8 ONY Biotech
  44. 4.8.1 ONY Biotech Company Information
  45. 4.8.2 ONY Biotech Business Overview
  46. 4.8.3 ONY Biotech Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 ONY Biotech Pulmonary Surfactant Product Portfolio
  48. 4.8.5 ONY Biotech Recent Developments
  49. 4.9 Lyomark Pharma
  50. 4.9.1 Lyomark Pharma Company Information
  51. 4.9.2 Lyomark Pharma Business Overview
  52. 4.9.3 Lyomark Pharma Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Lyomark Pharma Pulmonary Surfactant Product Portfolio
  54. 4.9.5 Lyomark Pharma Recent Developments
  55. 4.10 LSBio
  56. 4.10.1 LSBio Company Information
  57. 4.10.2 LSBio Business Overview
  58. 4.10.3 LSBio Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 LSBio Pulmonary Surfactant Product Portfolio
  60. 4.10.5 LSBio Recent Developments
  61. 4.11 Creative Diagnostics
  62. 4.11.1 Creative Diagnostics Company Information
  63. 4.11.2 Creative Diagnostics Business Overview
  64. 4.11.3 Creative Diagnostics Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Creative Diagnostics Pulmonary Surfactant Product Portfolio
  66. 4.11.5 Creative Diagnostics Recent Developments
  67. 4.12 Boehringer Ingelheim
  68. 4.12.1 Boehringer Ingelheim Company Information
  69. 4.12.2 Boehringer Ingelheim Business Overview
  70. 4.12.3 Boehringer Ingelheim Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Boehringer Ingelheim Pulmonary Surfactant Product Portfolio
  72. 4.12.5 Boehringer Ingelheim Recent Developments
  73. 4.13 Biorbyt
  74. 4.13.1 Biorbyt Company Information
  75. 4.13.2 Biorbyt Business Overview
  76. 4.13.3 Biorbyt Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Biorbyt Pulmonary Surfactant Product Portfolio
  78. 4.13.5 Biorbyt Recent Developments
  79. 4.14 Biomatik
  80. 4.14.1 Biomatik Company Information
  81. 4.14.2 Biomatik Business Overview
  82. 4.14.3 Biomatik Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Biomatik Pulmonary Surfactant Product Portfolio
  84. 4.14.5 Biomatik Recent Developments
  85. 4.15 Aviva Systems Biology
  86. 4.15.1 Aviva Systems Biology Company Information
  87. 4.15.2 Aviva Systems Biology Business Overview
  88. 4.15.3 Aviva Systems Biology Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Aviva Systems Biology Pulmonary Surfactant Product Portfolio
  90. 4.15.5 Aviva Systems Biology Recent Developments
5 Global Pulmonary Surfactant Market Scenario by Region
  1. 5.1 Global Pulmonary Surfactant Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pulmonary Surfactant Sales by Region: 2021-2032
  3. 5.2.1 Global Pulmonary Surfactant Sales by Region: 2021-2026
  4. 5.2.2 Global Pulmonary Surfactant Sales by Region: 2027-2032
  5. 5.3 Global Pulmonary Surfactant Revenue by Region: 2021-2032
  6. 5.3.1 Global Pulmonary Surfactant Revenue by Region: 2021-2026
  7. 5.3.2 Global Pulmonary Surfactant Revenue by Region: 2027-2032
  8. 5.4 North America Pulmonary Surfactant Market Facts & Figures by Country
  9. 5.4.1 North America Pulmonary Surfactant Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pulmonary Surfactant Sales by Country (2021-2032)
  11. 5.4.3 North America Pulmonary Surfactant Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Pulmonary Surfactant Market Facts & Figures by Country
  16. 5.5.1 Europe Pulmonary Surfactant Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Pulmonary Surfactant Sales by Country (2021-2032)
  18. 5.5.3 Europe Pulmonary Surfactant Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Pulmonary Surfactant Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Pulmonary Surfactant Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Pulmonary Surfactant Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Pulmonary Surfactant Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Pulmonary Surfactant Market Facts & Figures by Country
  41. 5.7.1 South America Pulmonary Surfactant Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Pulmonary Surfactant Sales by Country (2021-2032)
  43. 5.7.3 South America Pulmonary Surfactant Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Pulmonary Surfactant Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Pulmonary Surfactant Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Pulmonary Surfactant Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Pulmonary Surfactant Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Pulmonary Surfactant Sales by Type (2021-2032)
  2. 6.1.1 Global Pulmonary Surfactant Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Pulmonary Surfactant Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pulmonary Surfactant Revenue by Type (2021-2032)
  5. 6.2.1 Global Pulmonary Surfactant Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pulmonary Surfactant Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pulmonary Surfactant Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pulmonary Surfactant Sales by Application (2021-2032)
  2. 7.1.1 Global Pulmonary Surfactant Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Pulmonary Surfactant Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pulmonary Surfactant Revenue by Application (2021-2032)
  5. 7.2.1 Global Pulmonary Surfactant Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pulmonary Surfactant Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pulmonary Surfactant Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pulmonary Surfactant Value Chain Analysis
  2. 8.1.1 Pulmonary Surfactant Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pulmonary Surfactant Production Mode & Process
  5. 8.2 Pulmonary Surfactant Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pulmonary Surfactant Distributors
  8. 8.2.3 Pulmonary Surfactant Customers
9 Global Pulmonary Surfactant Analyzing Market Dynamics
  1. 9.1 Pulmonary Surfactant Industry Trends
  2. 9.2 Pulmonary Surfactant Industry Drivers
  3. 9.3 Pulmonary Surfactant Industry Opportunities and Challenges
  4. 9.4 Pulmonary Surfactant Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst